{"id":2984,"date":"2023-10-26T12:13:25","date_gmt":"2023-10-26T11:13:25","guid":{"rendered":"https:\/\/www.blowclinic.com\/nickmaycock\/?post_type=treatment&p=2984"},"modified":"2024-01-04T09:24:40","modified_gmt":"2024-01-04T09:24:40","slug":"corneal-crosslinking","status":"publish","type":"treatment","link":"https:\/\/nickmaycock.co.uk\/treatments\/corneal-crosslinking","title":{"rendered":"CORNEAL CROSSLINKING"},"content":{"rendered":"
Keratoconus is a non-inflammatory eye condition that can causes the cornea to thin and form a cone shape. <\/span><\/p>\n This causes blurred vision. The condition usually starts in the mid-late teenage years and can progress up to around the of 40yrs old. As we age the cornea naturally stiffens leading to the disease naturally burning out. Occasionally it may continue to progress beyond this age. Corneal crosslinking (CXL) is a preventative procedure that mimics this naturally occurring stiffening and stabilises the corneal shape preventing any further progression of keratoconus.<\/a>\u00a0<\/span><\/p>\n Corneal crosslinking involves the administration of riboflavin (vitamin B2) onto the cornea once the epithelium has been removed. This allows it soak into the cornea. UV-A light is then applied to the cornea, which causes the formation of new bonds within the corneal collagen structure making it stiffer and halting further progression of the keratoconus.\u00a0<\/span><\/p>\n The CXL procedure can be varied to allow thin corneas to be treated.\u00a0<\/span><\/p>\n","protected":false},"featured_media":3069,"parent":0,"menu_order":7,"template":"","class_list":["post-2984","treatment","type-treatment","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\n